Copyright
©The Author(s) 2016.
World J Gastroenterol. Apr 7, 2016; 22(13): 3602-3610
Published online Apr 7, 2016. doi: 10.3748/wjg.v22.i13.3602
Published online Apr 7, 2016. doi: 10.3748/wjg.v22.i13.3602
Table 4 Long-term outcomes n (%)
| L-TME | R-TME | P value | |
| (n = 58) | (n = 53) | ||
| Adjuvant chemotherapy | 25 (43.1) | 27 (50.9) | 0.700 |
| Distant recurrence | 5 (8.6) | 9 (17.0) | 0.265 |
| Local recurrence | 3 (5.2) | 1 (1.9) | 0.618 |
| Overall mortalit | 6 (10.3) | 5 (9.4) | 0.564 |
| Mortality for rectal cancer | 4 (6.9) | 4 (7.5) | 0.491 |
| 3-yr overall survival (%) | 90.0 | 90.2 | 0.956 |
| 3-yr disease-free survival (%) | 83.4 | 79.2 | 0.268 |
- Citation: Feroci F, Vannucchi A, Bianchi PP, Cantafio S, Garzi A, Formisano G, Scatizzi M. Total mesorectal excision for mid and low rectal cancer: Laparoscopic vs robotic surgery. World J Gastroenterol 2016; 22(13): 3602-3610
- URL: https://www.wjgnet.com/1007-9327/full/v22/i13/3602.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i13.3602